Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: cholelithiasis major surgical or invasive procedure: : 1. cholecystectomy with transcystic common bile duct exploration. 2. pseudocyst gastrostomy. 3. pancreatic necrotectomy. history of present illness: the patient is a 70f with pmh of htn, pvd and dm s/p very complicated hospitalization at from for necrotizing gallstone pancreatitis, respiratory failure requiring intubation, development of vap and arf presents now with abdominal pain. she originally presented to where ct scan demonstrated a pancreatic pseudocyst. this prompted a transfer to . since her discharge from on , she has been doing well; she was in rehab until . since then she has been home, tolerating some regular diet, and increasing her daily activities. however approximately 1 week ago, she developed increased abdominal pain, radiating to the back, with several episodes emesis. as the pain worsened, she presented to lgh on where ruq ultrasound demonstrated gallstones, and a ct demonstrated a pancreatic pseudocyst. the patient was evaluated by dr. for surgical drainage of the pancreatic pseudocyst and open ccy. elective surgery was scheduled on . past medical history: pmh diabetes type ii, hypertension, hyperlipidemia, necrotizing pancreatitis with respiratory failure/ards, and , mild dementia social history: from the republic, lives with her husband. smoking, alcohol, drugs. daughter - family history: fh negative for gallstones physical exam: on discharge: vs: 98.8, 94, 153/79, 12, 96% ra gen: nad cv: rrr resp: ctab abd: midline abdominal incision open to air with steri strips and c/d/i. llq old jp site with occlusive dressing and c/d/i extr: warm, no c/c/e pertinent results: 08:45am blood wbc-10.2# rbc-4.16* hgb-11.6* hct-36.5 mcv-88 mch-28.0 mchc-31.9 rdw-14.3 plt ct-755*# 05:20pm blood glucose-246* urean-4* creat-0.3* na-138 k-3.6 cl-95* hco3-33* angap-14 09:38pm blood calcium-7.9* phos-2.2*# mg-1.5* 11:15 am stool consistency: not applicable source: stool. c. difficile dna amplification assay (pending): brief hospital course: the patient was admitted to the general surgical service for elective surgical drainage of the pancreatic pseudocyst and cholecystectomy. on , the patient underwent cholecystectomy with transcystic common bile duct exploration, pseudocyst gastrostomy and pancreatic necrosectomy, which went well without complication (reader referred to the operative note for details). after a brief, uneventful stay in the pacu, the patient arrived on the floor npo with ngt, on iv fluids, with a foley catheter, and epidural for pain control. the patient was hemodynamically stable. neuro: the patient received dilaudid/hydromorphone via epidural catheter with good effect and adequate pain control. when tolerating oral intake, the patient was transitioned to oral pain medications. cv: the patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. pulmonary: the patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization. patient was restarted on her home lasix dose prior discharge. gi: post-operatively, the patient was made npo with iv fluids. diet was advanced on pod # 4, which was well tolerated. patient's intake and output were closely monitored, and iv fluid was adjusted when necessary. electrolytes were routinely followed, and repleted when necessary. jp drain was removed on pod # 6 as output was low. the patient developed diarrhea with undigested food visible in her stool. c-diff was sent and was negative. the patient was started on po pancreatic enzymes with every meal and her diarrhea subsided prior discharge home. id: the patient's white blood count and fever curves were closely watched for signs of infection. wound was evaluated daily and no signs or symptoms of infection were noticed. staples were removed prior discharge and steri strips were applied. endocrine: the patient with a history of dm ii was kept on insulin sliding scale immediately post op. her blood sugars were elevated and was called for consult. patient was started on basal insulin and her dose was titrated to 8 units qhs. she also was restarted on po metformin prior discharge. patient primary care physician was notified about above changes. the patient will follow up with her pcp next week to continue insulin adjustment and blood sugar monitoring. the patient was discharge home on regular diabetic diet with glucerna shakes. hematology: the patient's complete blood count was examined routinely; no transfusions were required. prophylaxis: the patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. at the time of discharge, the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diabetic diet, ambulating with walker, voiding without assistance, and pain was well controlled. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: insulin glargine 15 units qhs, galantamine 8 mg daily with food, lasix 20 mg po daily, lisinopril 20 mg daily, loratadine 10 mg daily, metformin 1000 mg , metoprolol tartrate 25 mg , omeprazole 40 mg daily, pravastatin 40 mg daily, verapamil 80 mg q8, colace 100 mg po bid, ferrous sulfate 325 mg po daily, daily simethicone discharge medications: 1. acetaminophen 650 mg po q8h 2. calcium carbonate 500 mg po qid:prn indigestion 3. creon 12 2 cap po tid w/meals rx *lipase-protease-amylase 5,000 unit-,000 unit-,000 unit capsule(s) by mouth qac disp #*180 capsule refills:*2 4. furosemide 20 mg po daily 5. galantamine *nf* 8 mg oral daily reason for ordering: wish to maintain preadmission medication while hospitalized, as there is no acceptable substitute drug product available on formulary. 6. lisinopril 20 mg po daily 7. metformin (glucophage) 1000 mg po bid 8. metoprolol tartrate 25 mg po bid 9. oxycodone (immediate release) 5 mg po q4h:prn pain rx *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours disp #*60 tablet refills:*0 10. omeprazole 40 mg po daily 11. pravastatin 40 mg po daily 12. tramadol (ultram) 25 mg po q6h:prn pain rx *tramadol 50 mg 0.5 (one half) tablet(s) by mouth every six (6) hours disp #*30 tablet refills:*0 13. verapamil 80 mg po q8h 14. ferrous sulfate 325 mg po daily 15. glucerna shake *nf* (nut.tx.gluc.intol,lac-free,soy) 1 can oral qac with breakfast, lunch and dinner rx *nut.tx.gluc.intol,lac-free,soy 1 can by mouth qac disp #*90 unit refills:*0 16. glargine 8 units bedtime discharge disposition: home with service facility: , discharge diagnosis: 1. pancreatic pseudocyst 2. chronic cholecystitis and cholelithiasis discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - requires assistance or aid (walker or cane). discharge instructions: you were admitted to the surgery service at for surgical drainage of your pancreatic cyst. you have done well in the post operative period and are now safe to return home to complete your recovery with the following instructions: please resume all regular home medications , unless specifically advised not to take a particular medication. also, please take any new medications as prescribed. please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. avoid lifting weights greater than lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. avoid driving or operating heavy machinery while taking pain medications. please follow-up with your surgeon and primary care provider (pcp) as advised. incision care: *please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *avoid swimming and baths until your follow-up appointment. *you may shower, and wash surgical incisions with a mild soap and warm water. gently pat the area dry. *if you have staples, they will be removed at your follow-up appointment. *if you have steri-strips, they will fall off on their own. please remove any remaining strips 7-10 days after surgery. followup instructions: department: surgical specialties when: friday at 8:45 am with: , md building: sc clinical ctr campus: east best parking: garage . please follow up with dr. (pcp) in weeks after discharge procedure: cholecystectomy insertion of catheter into spinal canal for infusion of therapeutic or palliative substances systemic to pulmonary artery shunt other excision or destruction of lesion or tissue of pancreas or pancreatic duct exploration of common duct gastrotomy other pancreatotomy diagnoses: unspecified pleural effusion unspecified essential hypertension peripheral vascular disease, unspecified personal history of tobacco use other and unspecified hyperlipidemia calculus of gallbladder with other cholecystitis, without mention of obstruction long-term (current) use of insulin other ascites diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other specified diseases of pancreas cyst and pseudocyst of pancreas unspecified pruritic disorder 

Answer: The patient is high likely exposed to